Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NPC-06 for cancer-related neuropathic pain
NCT03773055Phase 2Terminated
- Sponsor
- Nobelpharma Co., Ltd.
- Start
- Apr 2019
- Primary completion
- Sep 2020
- Modality
- Prodrugs/Conditional Activator Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of fosphenytoin in neuropathic pain (3 arms), sponsored by Nobelpharma Co., Ltd. Primary endpoint: Improvement of Numeric Rating Scale (NRS) score within 2 hours after administration. Started Apr 2019; status: terminated.
02
Drugs
fosphenytoin
03
Conditions
neuropathic pain
Beyond the preview
Go deeper on NCT03773055.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03773055.